Table 2.
Patterns of use and illness/es treated
| Total sample (n = 2.841) | Substitution users (n = 1.546) | Odds of substituting | |
|---|---|---|---|
| N (%) | N (%) | OR (95% CI) | |
| Types of cannabis | |||
| THC-oil | 697 (24.5) | 415 (26.8) | 1.28* (1.07–1.53) |
| CBD-oil | 1.850 (65.1) | 1.008 (65.2) | 0.96 (0.81–1.13) |
| Hash, pot or skunk | 1.035 (36.4) | 566 (36.6) | 1.16 (0.97–1.38) |
| Cannabis based (Marinol, Sativex) | 172 (6.1) | 105 (6.8) | 1.22 (0.89–1.69) |
| Whole plant trial (Bedrocan, Bediol) | 54 (1.9) | 34 (2.2) | 1.42 (0.81–2.51) |
| Other | 221 (7.8) | 124 (8) | 1.03 (0.78–1.37) |
| Respondents only using CBD oil | 1.086 (38.2) | 560 (36.2) | 0.79* (0.67–0.93) |
| Frequency of use | |||
| 6–7 days a week | 2.141 (75.4) | 1.197 (77.4) | 1.00 (reference) |
| 3–5 days a week | 366 (12.9) | 187 (12.1) | 0.86 (0.69–1.08) |
| 1–2 days a week | 162 (5.7) | 76 (4.9) | 0.78 (0.56–1.08) |
| A few times a month | 92 (3.2) | 45 (2.9) | 0.83 (0.54–1.27) |
| Very rarely | 50 (1.8) | 24 (1.6) | 0.74 (0.42–1.31) |
| Missing | 30 (1.1) | 17 (1.1) | |
| Most frequent form of intake | |||
| Smoked | 686 (24.2) | 355 (23) | 0.94 (0.76–1.13) |
| Vaporized | 102 (3.6) | 54 (3.5) | 1.03 (0.69–1.56) |
| Oil | 1.601 (56.4) | 861 (55.7) | 0.87 (0.74–1.02) |
| Edibles, suppositories, tea, topical | 142 (5) | 87 (5.6) | 1.37 (0.96–1.95) |
| Capsules | 119 (4.2) | 71 (4.6) | 1.23 (0.84–1.79) |
| Other | 172 (6.1) | 107 (6.9) | 1.35 (0.97–1.86) |
| Missing | 19 (0.6) | 11 (0.7) | |
| Level of recreational experience | |||
| Novice (lifetime use < 5 times) | 1.803 (63.5) | 991 (64.1) | 1.00 (reference) |
| Experienced (lifetime use > 5 times) | 981 (34.5) | 531 (34.4) | 1.08 (0.90–1.28) |
| Missing | 57 (2) | 24 (1.6) | |
| Prescription for medical cannabis | |||
| No | 2.586 (91) | 1.381 (89.3) | 1.00 (reference) |
| Yes | 238 (8.4) | 162 (10.5) | 1.68*** (1.26–2.24) |
| Missing | 17 (0.6) | 3 (0.2) | |
| User status | |||
| Current user of CaM | 2.588 (91.1) | 1.414 (91.5) | 1.00 (reference) |
| Former user of CaM | 253 (8.9) | 132 (8.5) | 0.94 (0.72–1.23) |
| Illnesses treated with CaM | |||
| Somatic condition | 2.083 (73.3) | 1.196 (77.4) | 1.44*** (1.21–1.71) |
| Psychiatric condition | 1.055 (37.1) | 593 (38.4) | 1.15 (0.98–1.35) |
| Chronic pain | 932 (32.8) | 642 (41.5) | 2.30*** (1.94–2.72) |
| Sleep disturbances | 793 (27.9) | 443 (28.7) | 1.09 (0.92–1.29) |
| Stress | 684 (24.1) | 351 (22.7) | 0.91 (0.76–2.94) |
| Mean number of conditions treated with CaM | 3.2 (SD 2.5) | 3.6 (SD 2.6)*** | z = − 9.01, r = − 0.17 |
For overview of Somatic and Psychiatric conditions see “Appendix 2”
OR odds ratio; CI confidence interval
*p < 0.05; ***p < 0.001